Antibody levels after BNT162b2 vaccine booster and SARS-CoV-2 Omicron infection

Autor: Vietri, Maria Teresa, D'Elia, Giovanna, Caliendo, Gemma, Passariello, Luana, Albanese, Luisa, Maria Molinari, Anna, Francesco Angelillo, Italo
Přispěvatelé: Vietri, Maria Teresa, D'Elia, Giovanna, Caliendo, Gemma, Passariello, Luana, Albanese, Luisa, Maria Molinari, Anna, Francesco Angelillo, Italo
Rok vydání: 2022
Předmět:
Zdroj: Vaccine. 40:5726-5731
ISSN: 0264-410X
DOI: 10.1016/j.vaccine.2022.08.045
Popis: In the present study, immunogenicity data in 61 vaccinated healthcare workers (HCWs) either infection naïve (naïve HCWs) or with infection of Delta and/or Omicron COVID-19 (experienced HCWs) were evaluated up to 270days after the second dose of BNT162b2 vaccine and up to 90days after a booster dose. A decrease in antibody levels at 270days following administration of the second dose (p=0.0335) was observed, although values did not fall below the positivity threshold (33.8 BAU/ml). After booster vaccination, antibody levels increased after 30days (p=0.0486), with much higher values than after first and second vaccination. Antibody levels then decreased at 60 and 90days after the booster dose. A comparison between mean antibody levels of naïve and experienced HCWs revealed higher values in experienced HCWs, resulting from both natural and vaccination-induced immunity. A total of 14.7% of HCWs contracted the Omicron virus variant after the vaccine booster, although none showed severe symptoms. These results support that a booster dose results in a marked increase in antibody response that subsequently decreases over time.
Databáze: OpenAIRE